Ferguson Enterprises Inc. (“Company”): Execution of Rule 10b5-1 Plan
NEWPORT NEWS, Va.–(BUSINESS WIRE)–This is an initial notification of a transaction of a person discharging managerial responsibility (“PDMR”) in... Read more.
DFNS Rebrands as the Core Banking Platform for Digital Assets
PARIS–(BUSINESS WIRE)–DFNS today announced a rebrand, marking its evolution from a wallet infrastructure to the first core banking platform for digital... Read more.
Phase III FIND‑CKD Results Show Bayer’s KERENDIA® (finerenone) Improved eGFR Slope and Reduced Risk of a Composite Kidney-Cardiovascular Outcome in Adults with Non‑Diabetic Chronic Kidney Disease
Investigational results from FIND-CKD provide full efficacy and safety data and is the fifth consecutive Phase III clinical trial where KERENDIA met its primary... Read more.
CACI to Participate in the 16th Annual Wells Fargo Industrials & Materials Conference
RESTON, Va.–(BUSINESS WIRE)–#LimitlessPotential–CACI International Inc (NYSE: CACI) announced today that it will participate in the 16th Annual... Read more.
MTF Biologics Expands FlexHD® Reconstructive Surgery Portfolio With Launch of FlexHD® Meshed
Pre-meshed acellular dermal allograft developed to deliver fast, flexible, coverage for complex soft tissue defects in surgical procedures — without intraoperative... Read more.
MTF Biologics Expands FlexHD® Reconstructive Surgery Portfolio With Launch of FlexHD® Meshed
Pre-meshed acellular dermal allograft developed to deliver fast, flexible, coverage for complex soft tissue defects in surgical procedures — without intraoperative... Read more.
Locala Appoints Grant Gudgel as Chief Marketing Officer
NEW YORK–(BUSINESS WIRE)–#AI—Locala today announced the appointment of Grant Gudgel as Chief Marketing Officer, as the company prepares to introduce... Read more.
Locala Appoints Grant Gudgel as Chief Marketing Officer
NEW YORK–(BUSINESS WIRE)–#AI—Locala today announced the appointment of Grant Gudgel as Chief Marketing Officer, as the company prepares to introduce... Read more.
Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress
Patients in the study who initiated and remained on FILSPARI maintained durable and deepened proteinuria reductions, resulting in further achievement of clinically... Read more.
Using Uniswap Just Got Easier: In-App Wallet, Crosschain Swaps, and Portfolio Tracking
NEW YORK–(BUSINESS WIRE)–Uniswap Labs today announced four updates across Uniswap apps that make it easier for people to get started onchain, track their... Read more.